2022
DOI: 10.1109/jsen.2022.3143176
|View full text |Cite
|
Sign up to set email alerts
|

Development of Wavelet Coherence EEG as a Biomarker for Diagnosis of Major Depressive Disorder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(17 citation statements)
references
References 41 publications
3
14
0
Order By: Relevance
“…In order to further verify the ability of the proposed model to classify MDD patients and HCs, this paper designed subject-dependent experiments based on the EEG data of MDD patients and HCs as previous studies [37], [38]. Concretely, the proposed model and the five comparison models were carried out five rounds of 10-fold CV experiments.…”
Section: Further Studymentioning
confidence: 99%
“…In order to further verify the ability of the proposed model to classify MDD patients and HCs, this paper designed subject-dependent experiments based on the EEG data of MDD patients and HCs as previous studies [37], [38]. Concretely, the proposed model and the five comparison models were carried out five rounds of 10-fold CV experiments.…”
Section: Further Studymentioning
confidence: 99%
“…Nonetheless, in an electroencephalography study a CNN relying on wavelet coherence of the DMN was able to reliably classify MDD patients with over 98%. 124 Concluding, there is a promise in neurodynamic analyses for identifying MDD-associated biomarkers, but the limited number of studies so far only led to a relatively consistent finding of the instability of the DMN network in MDD. More consistent findings of other potentially affected networks related to MDD are needed to draw reliable conclusions.…”
Section: Functional Neurodynamicsmentioning
confidence: 99%
“…To date, no depression fMRI study has implemented wavelet coherence. Nonetheless, in an electroencephalography study a CNN relying on wavelet coherence of the DMN was able to reliably classify MDD patients with over 98% 124 …”
Section: Future Opportunitiesmentioning
confidence: 99%
“…Machine learning (ML) methods are of increasing interest for the medical industry at present, and it has emerged as an essential part of the diagnosis and treatment of conditions pertaining to oncology, neurology, and cardiology. The process involved in a typical deep learning pipeline for the identification of MDD can be highlighted as follows: region of interest (ROI) extraction from R-fMRI, functional connectivity matrix generation, graph construction, deep learning model training, and classification ( 9 ). Figure 1 depicts the processes required in identifying MDD from HCs.…”
Section: Introductionmentioning
confidence: 99%